Hinge Health’s 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care
Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026
Hinge Health (NYSE:HNGE) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Hinge Health (NYSE:HNGE) was given a new $60.00 price target on by analysts at Piper Sandler.
Hinge Health (NYSE:HNGE) was given a new $68.00 price target on by analysts at Wells Fargo & Company. They now have an "overweight" rating on the stock.